HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

PF 04217329

a prodrug of CP-544326; structure in first source

Also Known As:

PF-04217329; PF04217329

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Almaden, Chau: 1 article (09/2011)
2.	Anderson, Scott: 1 article (09/2011)
3.	Carreiro, Samantha: 1 article (09/2011)
4.	Dinh, Dac: 1 article (09/2011)
5.	Fortner, Jay: 1 article (09/2011)
6.	Gale, David: 1 article (09/2011)
7.	Gukasyan, Hovhannes: 1 article (09/2011)
8.	Krauss, Achim: 1 article (09/2011)
9.	Lafontaine, Jennifer: 1 article (09/2011)
10.	Niesman, Michael: 1 article (09/2011)

Related Diseases

1.	Open-Angle Glaucoma (Glaucoma, Open Angle) 09/01/2011 - "Recently PF-04217329 (Taprenepag isopropyl), a prodrug of CP-544326 (active acid metabolite), a potent and selective EP(2) receptor agonist, was successfully evaluated for its ocular hypotensive activity in a clinical study involving patients with primary open angle glaucoma. "
2.	Glaucoma 09/01/2011 - "In conclusion, preclinical data generated thus far appear to support the clinical development of PF-04217329 as a novel compound for the treatment of glaucoma." 09/01/2011 - "Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma."

Related Drugs and Biologics

1.	Prostaglandins
2.	Prodrugs
3.	Acids
4.	CP 544326